Skip to main content
Terug
Watch Compare

SPRUCE BIOSCIENCES, INC.

Datakwaliteit: 100%
SPRB
Nasdaq Manufacturing Chemicals
€ 63,63
▼ € 2,38 (-3,61%)
Marktkapitalisatie: 91,38 M
Prijs
€ 66,61
Marktkapitalisatie
91,38 M
Dagbereik
—
52-Weeksbereik
—
Volume
—
Openen —
50D / 200D Gem.
—
50D / 200D Gem.
—

Quick Summary

Belangrijkste Punten

Debt/Equity of 0,10 — conservative balance sheet
Negative free cash flow of -33,33 M

Groei

Revenue Growth (5Y)
N/A
Revenue (1Y)-100,00%
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Kwaliteit

Return on Equity
-419,76%
Onder sectorgemiddelde (-53,41%)
ROIC-293,65%
Net MarginN/A
Op. MarginN/A

Veiligheid

Debt / Equity
0,10
Onder sectorgemiddelde (0,31)
Current Ratio1,54
Interest Coverage-405,70

Waardering

PE (TTM)
-2,35
Onder sectorgemiddelde (-1,48)
P/B Ratio16,97
EV/EBITDAN/A
Dividend YieldN/A

Koershistorie

Financiële Trends

Sectorvergelijking

vs Manufacturing sector mediaan (1364 peers)
Metriek Aandeel Sector Mediaan
P/E -2,4 -1,5
P/B 17,0 1,6
ROE % -419,8 -53,4
Net Margin % — -41,5
Rev Growth 5Y % — 1,8
D/E 0,1 0,3

All Fundamental Metrics
Growth
Revenue Growth (1Y) -100,00% Revenue Growth (3Y) N/A
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 0,0 Net Income (TTM) -38,97 M
ROE -419,76% ROA -209,87%
Gross Margin N/A Operating Margin N/A
Net Margin N/A Free Cash Flow (TTM) -33,33 M
ROIC -293,65% FCF Growth (3Y) N/A
Safety
Debt / Equity 0,10 Current Ratio 1,54
Interest Coverage -405,70 Asset Turnover 0,00
Working Capital 5,09 M Tangible Book Value 5,39 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -2,35 Forward P/E N/A
P/B Ratio 16,97 P/S Ratio N/A
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -36,47%
Market Cap 91,38 M Enterprise Value 81,26 M
Per Share
EPS (Diluted TTM) -50,83 Revenue / Share 0,00
FCF / Share -24,29 OCF / Share -24,29
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue N/A FCF Conversion 85,53%
SBC-Adj. FCF -35,35 M Growth Momentum N/A

Income Statement

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue 0,0 4,91 M 10,09 M — —
Net Income -38,97 M -53,04 M -47,92 M -46,18 M -42,29 M
EPS (Diluted) -50,83 -1,29 -1,24 -1,96 —
Gross Profit — — — — —
Operating Income -36,51 M -56,15 M -51,99 M -47,28 M -42,07 M
EBITDA — — — — —
R&D Expenses 19,52 M 46,42 M 49,43 M 35,20 M 30,70 M
SG&A Expenses — — — — —
D&A 21.000,0 46.000,0 70.000,0 74.000,0 68.000,0
Interest Expense 90.000,0 307.000,0 483.000,0 420.000,0 345.000,0
Income Tax 0,0 0,0 0,0 0,0 0,0

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 53,02 M 45,21 M 103,95 M 85,65 M 126,49 M
Total Liabilities 10,51 M 16,39 M 27,44 M 17,16 M 15,12 M
Shareholders' Equity 42,52 M 28,82 M 76,51 M 68,49 M 111,37 M
Total Debt 0,0 1,84 M 3,71 M 5,64 M 4,88 M
Cash & Equivalents 48,91 M 38,75 M 96,34 M 24,49 M 42,75 M
Current Assets 52,11 M 44,21 M 102,18 M 83,61 M 91,90 M
Current Liabilities 10,09 M 15,25 M 24,47 M 12,45 M 8,87 M